does medicaid pay for tirzepatide Medicare to Cover Blockbuster Obesity Drugs US states drop Medicaid coverage

Reinhardt, C

Perform biological activity testing, such as in vitro cell experiments or in vivo animal experiments, to re validate the pharmacological properties of the drug, ensuring that it can effectively activate GLP-1 receptors, exert the effects of lowering blood sugar and controlling weight

Uncontrolled cardiovascular disease: Blood pressure and heart rate effects pose additional risk

While this delayed stomach clearing helps you feel fuller longer, it can trigger sensations of bloating, pressure, and stomach pain, especially when you eat larger meals or foods high in fat

The evidence STEP (NEJM 2021), SURMOUNT (NEJM 2022), SURMOUNT-OSA (NEJM 2024) attaches to the compound, not to the brand delivering it